Statin drug use is not associated with prostate cancer risk in men who are regularly screened.

[1]  S. Vinker,et al.  Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study , 2013, Prostate Cancer and Prostatic Disease.

[2]  Chun-Yuh Yang,et al.  Statins increase the risk of prostate cancer: A population‐based case–control study , 2011, The Prostate.

[3]  B. Caffo,et al.  Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study. , 2011, Cancer epidemiology.

[4]  Leonard W. D'Avolio,et al.  Statins and prostate cancer diagnosis and grade in a veterans population. , 2011, Journal of the National Cancer Institute.

[5]  E. Crawford,et al.  Effect of Statins on Serum Prostate-specific Antigen Levels. , 2010, Urology.

[6]  T. Tammela,et al.  Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial , 2010, International journal of cancer.

[7]  B. Strom,et al.  Statin and NSAID use and prostate cancer risk , 2010, Pharmacoepidemiology and drug safety.

[8]  D. Boudreau,et al.  Statin use and cancer risk: a comprehensive review , 2010, Expert opinion on drug safety.

[9]  E. Platz,et al.  Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004 , 2010, Cancer Causes & Control.

[10]  P. Goodman,et al.  Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[11]  E. Platz,et al.  The influence of statin medications on prostate-specific antigen levels. , 2008, Journal of the National Cancer Institute.

[12]  S. Bonovas,et al.  Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies , 2008, International journal of cancer.

[13]  T. Tammela,et al.  Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[14]  D. Kadmon,et al.  The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. , 2005, The Journal of urology.

[15]  J. Crowley,et al.  Implementation of the Prostate Cancer Prevention Trial (PCPT). , 2004, Controlled clinical trials.

[16]  Michael M Lieber,et al.  Journal Review , 2003, International Society of Hair Restoration Surgery.

[17]  D. Siegel,et al.  Use of cholesterol-lowering medications in the United States from 1991 to 1997. , 2000, The American journal of medicine.

[18]  D. Gordon,et al.  Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. , 1998, Archives of internal medicine.

[19]  S. Falahatkar,et al.  Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males. , 2011, Acta medica Iranica.

[20]  J. Lonnqvist,et al.  Incidence of cancer and statin usage—Record linkage study , 2010, International journal of cancer.